Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Natera Shares Are Trading Higher After Canaccord Genuity Raised Its Price Target on the Stock From $165 to $180.
Natera Analyst Ratings
Viking Therapeutics Among Potential Buyout Candidates: Oppenheimer
ACADIA Pharmaceuticals Analyst Ratings
Santa Claus Came Without Rallying the Troops | Live Stock
Acadia Pharmaceuticals, FTAI Aviation And Other Big Stocks Moving Higher On Tuesday
Top U.S. Health Care Mid-cap Stocks and Their Quant Ratings
Biggest Stock Movers Tuesday: VSTM, ACAD
Corcept Therapeutics Submits New Drug Application To FDA For Its Proprietary, Selective Cortisol Modulator, Relacorilant, To Treat Patients With Cushing's Syndrome
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
Mizuho CEO Sees Global Boom in M&A After Trump Takes Office
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs